Cellectis (CLLS) Misses Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts CLLS Hot Sheet
Join SI Premium – FREE
Cellectis (NASDAQ: CLLS) reported Q3 EPS of ($0.23), $0.03 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $18.05 million versus the consensus estimate of $9.77 million.
For earnings history and earnings-related data on Cellectis (CLLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
- Bending Spoons valuation up to $19 Billion in U.S. IPO - Reuters
- Trump praises IBM CEO
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
